Icon Library
 > 
Cell Types
 > 
Epithelial Cells
 > 
Ciliated epithelial cell 1 (damaged)
BioRender Icon

Ciliated epithelial cell 1 (damaged)

Ciliated epithelial cell 1 (damaged) - Editable icon of Ciliated epithelial cell 1 (damaged)
[{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b998/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b998/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b999/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b999/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b99a/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b99a/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b99b/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b99b/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b99c/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b99c/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b99d/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b99d/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b99e/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b99e/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b99f/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b99f/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9a0/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9a0/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9a1/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9a1/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9a2/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9a2/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9a3/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9a3/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9a4/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9a4/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9a5/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9a5/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9a6/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9a6/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9a7/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9a7/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9a8/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9a8/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9a9/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9a9/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9aa/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9aa/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9ab/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9ab/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9ac/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9ac/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9ad/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9ad/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9ae/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9ae/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9af/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9af/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9b0/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9b0/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9b1/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9b1/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9b2/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9b2/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9b3/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9b3/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9b4/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9b4/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9b5/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9b5/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9b6/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9b6/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9b7/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9b7/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9b8/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9b8/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9b9/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9b9/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9ba/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9ba/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9bb/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9bb/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9bc/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9bc/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9bd/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9bd/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9be/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9be/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9bf/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9bf/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9c0/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9c0/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9c1/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9c1/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9c2/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9c2/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9c3/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9c3/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9c4/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9c4/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9c5/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9c5/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9c6/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9c6/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9c7/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9c7/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9c8/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9c8/5d1e63b909f8320400b7f3ca.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df46beed9462577e08b9c9/5d1e63b909f8320400b7f3ca.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df46beed9462577e08b9c9/5d1e63b909f8320400b7f3ca.png"}]
Use This Icon – Free
No credit card required to sign up.

This icon is fully editable in BioRender

  • Add text, shapes, & other icons
  • Search 50,000+ scientifically accurate icons
  • Recolor and rearrange every icon, line, & label
  • Export or share for any use case
Scientist Avatars

Join 4M+ scientists already making publication-ready figures

compliance icon

BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More

Go from icons to finished figure – in minutes

  • Search from 50,000+ scientifically accurate, peer-reviewed icons
  • Customize with labels, shapes, and additional icons – everything is completely editable
  • Export or share your figures with collaborators
    ‍
Sign Up Free

Not quite the right icon? Discover more.

Search 50,000+ icons across 30+ life-science fields.

search icon
arrow-right
keyword text
Keywords
epithelium,columnar,epithelia,cilia,ciliated,damage,atrophy,pseudostratified epithelium,pseudostratified epithelial cell ciliated
Load More
View More

Try a synonym, or sign up to request an icon from the app.

Image types

Ciliated epithelial cell 1 (damaged) icon JPEG

Ciliated epithelial cell 1 (damaged) icon PNG

Ciliated epithelial cell 1 (damaged) icon SVG

Ciliated epithelial cell 1 (damaged) icon GIF

More Icons like this one in
Epithelial Cells

Enterocyte (epithelial–mesenchymal transition, stage 4)

Enterocyte (epithelial–mesenchymal transition, stage 2)

Enterocyte (epithelial–mesenchymal transition, stage 0)

Enterocyte (epithelial–mesenchymal transition, stage 3)

Enterocyte (epithelial–mesenchymal transition, stage 1)

L-cell (releasing GLP-1, schematic)

L-cell (releasing GLP-1)

L-cell

Biorender Icon FAQs

How are scientists using the Ciliated epithelial cell 1 (damaged) icon in their work?

BioRender users often use the Ciliated epithelial cell 1 (damaged) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Ciliated epithelial cell 1 (damaged) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Ciliated epithelial cell 1 (damaged) icon customizable in BioRender?

Most icons in BioRender, including the Ciliated epithelial cell 1 (damaged) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Ciliated epithelial cell 1 (damaged) icon for publication or presentations?

Yes, figures containing the Ciliated epithelial cell 1 (damaged) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Ciliated epithelial cell 1 (damaged) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Ciliated epithelial cell 1 (damaged) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Ciliated epithelial cell 1 (damaged) icon along with our library of more than 30,000 life science icons.

BioRender uses cookies to improve our user experience. By continuing to our site, you agree to our use of cookies outlined in our Privacy Policy.
Agree

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now
x icon